Email
Password
Remember meForgot password?
    Log in with Twitter
Press Release

Genome Editing Market Estimated To Display Significant Growth Of $8.1 Billion By 2025: Grand View Research Inc.


"Grand View Research, Inc. - Market Research And Consulting."
According to report published by Grand View Research, Key drivers attributing to the expansion of Genome Editing Market include Utilization of the technique in achievement of therapeutic genetic editing in infected cells and tissues, thereby removing deleterious mutations is anticipated to boost market with potential growth opportunities.

According to a report,"Genome Editing Market Analysis By Technology (CRISPR, TALEN, ZFN), By Delivery Method (Ex-vivo, In-vivo), By Application (Animal/Plant Cell Editing), By Service (In-house, Outsourced), By End-use And Segment Forecasts, 2018 - 2025", published by Grand View Research, Inc.,global genome editing market is anticipated to reach USD 8.1 billion by 2025, Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.

Key Takeaways from the report:

  • There has been great excitement surrounding the highly adaptable CRISPR technology.

  • The increased ease of retargeting and the ability to multiplex goes a long way toward explaining the speed with which CRISPR-centric companies have sprung up.

  • Ex-vivo mode of delivery accounted for the largest share of the revenue.

  • Therapy through ex-vivo mode of delivery allow the control over the specific dosage of therapeutic molecules delivered to cells.

  • Cell line engineering dominated with respect to revenue generation owing to the high utilization of technology in stem cell engineering.

  • There is comparatively, higher adoption of the technology in the biotechnology and pharmaceutical organizations for the purpose of therapeutic development.

  • Availability of other services such as gRNA library production and screening service along with editing is anticipated to propel growth in the outsourcing services.

  • Asia Pacific is anticipated to witness fastest growth over the forecast period owing to rising penetration of technology in comparatively immature market.

  • Key players contributing in this market are Thermo Fisher Scientific, Inc., Sangamo, Editas Medicine, Recombinetics, Inc, Sigma Aldrich Corporation, CRISPR THERAPEUTICS, Intellia Therapeutics, Inc., Caribou Biosciences, Inc.

  • These participants are capitalizing on unique advantages offered by the nuclease technology, they are working on.

UK genome editing market, by end-use, 2014 - 2025 (USD Million)

UK genome editing market, by end-use, 2014 - 2025 (USD Million)

Browse More Reports in Biotechnology Industry:

•  Viral Vector & Plasmid DNA Manufacturing MarketViral and non-viral vectors have emerged as an efficient delivery mechanism for development of innovative medicines. Development of optimized large-scale production, harvest, and purification strategies play a vital role in achieving compliance with regulatory requirements in context to product purity and traceability. This also aids in acceleration of therapeutic development from clinical evaluation step to market approval.

Nucleic Acid Isolation and Purification MarketDecreasing cost of genetic sequencing, ongoing developments in genetics, personalized medicine, and diagnostics, and increasing automation and technological advancements in instruments and tools used for isolation and purification of polynucleotides are some of the key factors driving nucleic acid isolation & purification market.

Genome editing market, by region, 2015 (USD Million)

Genome editing market, by region, 2015 (USD Million)

The ability of genome editing therapies to offer a significant improvement over current treatment options is important in enabling editing technologies to capture significant revenue share. Improved efficacy, reduced side effects, and the potential for cure for specific diseases, can be attributed to induce growth in the coming years. 

Moreover, technological advancements with respect to the development of novel vectors for delivery is anticipated to fuel growth in the coming years. Rising competition amongst the operating entities in order to gain the larger share of revenue is also responsible for the projected growth. These companies leverage industry collaborations for the acceleration of diversified product pipelines. 

Grand View Research has segmented the molecular scissors/genome editing market on the basis of technology, delivery method, application, end-use, service, and region: 

Molecular Scissors/Genome Editing Technology Outlook (Revenue, USD Million, 2014 - 2025)

(CRISPR)/Cas9

TALENs/MegaTALs

ZFN

Others

Molecular Scissors/Genome Editing Delivery Method Outlook (Revenue, USD Million, 2014 - 2025)

Ex-Vivo

In-Vivo

Molecular Scissors/Genome Editing Application Outlook (Revenue, USD Million, 2014 - 2025)

Cell Line Engineering

Animal Genetic Engineering

Plant Genetic Engineering

Other Applications

Molecular Scissors/Genome Editing End-use Outlook (Revenue, USD Million, 2014 - 2025)

Biotechnology & Pharmaceutical Companies

Academic & Government Research Institutes

Contract Research Organizations

Molecular Scissors/Genome Editing Service Outlook (Revenue, USD Million, 2014 - 2025)

Contract

In-house

Molecular Scissors/Genome Editing Service Outlook (Revenue, USD Million, 2014 - 2025)

North America

U.S.

Canada

Europe

Germany

UK

Asia Pacific

Japan

China

Latin America

Brazil

Middle East and Africa (MEA)

South Africa

Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

For more information: www.grandviewresearch.com

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist - U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: Switzerland
Website: www.grandviewresearch.com/industry-analysis/genome-editing-market



Latest News
Top News